The HGR product is designed to deterine a persons drug taking status which it does quickly and efficiently.
The IMI product is as I understand it a predictive test which indicates the status of a persons heart condition.The test itself does not mean that a person who has had the test will necessarily live longer than a person who has not had the test.So the value in the IMI product is with doctors and related entities[drug companies etc.]Will this product ever see the light of day in third world countries and would this product necessarily reduce undetected heart conditions in a superior way to current medical western world technique?Any comments would be appreciated.
I hold both hgr and IMI stocks.
Cheers.
The HGR product is designed to deterine a persons drug taking...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.03M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000000 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 8588296 | 10 |
View Market Depth
| Last trade - 16.21pm 19/09/2025 (20 minute delay) ? |
| BPP (ASX) Chart |
Day chart unavailable